Panel discussion / Q&A - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.
Topic:
Lipids
Speaker:
Doctor C. Gibson (Boston, US)
Professor W. Koenig (Munich, DE)
Professor J. Jukema (Leiden, NL)
Sponsored by Pfizer, Inc.
Event:
ESC Congress 2016
Congress Presentation
About the speakers
Doctor C Michael Gibson
Harvard Medical School, Boston (United States of America)
16
presentations
1
follower
Professor Wolfgang Koenig
German Heart Center of Munich, Munich (Germany)
24
presentations
0
follower
Professor J Wouter Jukema
Leiden University Medical Center, Leiden (Netherlands (The))
20
presentations
0
follower
3 more presentations in this session
Welcome and introductions - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.
Speaker: Doctor C. Gibson (Boston, US)
Beyond statins: understanding unmet need across the CV risk continuum.
Speaker: Professor W. Koenig (Munich, DE)
Current challenges in CV risk reduction for high-risk primary and secondary prevention populations.
Speaker: Professor J. Jukema (Leiden, NL) Doctor C. Gibson (Boston, US)
Access the full session
Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations
Speakers:
Doctor C. Gibson, Professor W. Koenig, Professor J. Jukema, Doctor C. Gibson, Professor W. Koenig...
About the event
